Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | DDR1 | Q08345 | 3/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoylenurea SCHEMBL15949069 | 1.00 | PARP1 (0.35) | PARP1KDM4ECA12CA9L3MBTL1 | |
| Benzoylenurea SCHEMBL15948986 | 1.00 | PARP1 (0.35) | PARP1KDM4ECA12CA9L3MBTL1 | |
| SCHEMBL15184732 | 0.89 | CA12 (0.35) | CA12CA9DDR1 | |
| SCHEMBL1661036 | 0.89 | CA12 (0.35) | CA12CA9DDR1 | |
| SCHEMBL15184766 | 0.89 | CA12 (0.35) | CA12CA9DDR1 | |
| SCHEMBL1660919 | 0.80 | CA12 (0.35) | KDM4ECA12CA9DDR1 | |
| SCHEMBL12180420 | 0.79 | AR (0.35) | CA12CA9DDR1 | |
| SCHEMBL12180408 | 0.78 | KDM4E (0.36) | KDM4EDDR1ELANE | |
| SCHEMBL1661057 | 0.78 | AR (0.36) | CA12CA9DDR1 | |
| SCHEMBL957862 | 0.78 | AR (0.38) | KDM4ECA12CA9DDR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2468732-B1 | 1H-Quinazoline-2,4-diones | NOVARTIS AG (CH) | 2014-08-20 | — | — | EP | claimed |